Despite the benefits of targeting PR in cancer treatment, several challenges remain:
Resistance to hormone therapy: Some PR-positive cancers may develop resistance to hormone therapies over time. Heterogeneity: Tumors can exhibit heterogeneous expression of PR, complicating treatment decisions. Side effects: Hormone therapies can have significant side effects, impacting the quality of life for patients.